Contineum Therapeutics, Inc. (CTNM)
NASDAQ · Healthcare
Contineum Therapeutics, Inc. Total Liabilities 2023–2024
Contineum Therapeutics, Inc. annual/quarterly total liabilities history from 2023 to 2024. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Contineum Therapeutics, Inc. total liabilities for the quarter ending December 31, 2024 were 14.8M, a 159.22% increase year-over-year.
- Contineum Therapeutics, Inc. total liabilities for 2024 were 14.8M, a 159.22% increase from 2023.
- Contineum Therapeutics, Inc. total liabilities for 2023 were 5.7M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Contineum Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2024 | $15 |
| 2023 | $6 |
| Contineum Therapeutics, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2024-12-31 | $15 |
| 2023-12-31 | $6 |
Contineum Therapeutics, Inc. Total Liabilities — FAQ
Contineum Therapeutics, Inc. (CTNM) total liabilities over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTNM's total liabilities history?
The chart and table above show Contineum Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.